澳優(01717.HK)上半年權益持有人應占利潤1.8億元 同比增長24.1%
格隆匯8月27日丨澳優(01717.HK)發佈公吿,2025年中期期間集團整體收入達人民幣3,886.8百萬元,較2024年同期人民幣3,681.1百萬元增長人民幣205.7百萬元或5.6%。增長主要源於集團自家品牌配方羊奶粉(自家羊奶粉或佳貝艾特)海外市場表現優異,同比大幅增長65.7%,再次超越市場預期。其次,2024年10月,集團完成對荷蘭羊乳酪公司Amalthea Group B.V.餘下50%股份的戰略收購。這一重要佈局不僅實現了佳貝艾特核心產品原料的自主可控,更通過新增奶酪產品線進一步豐富集團業務版圖,為營收增長注入新動力。此外,營養品業務的突破亦帶來上半年營收的增量。截至2025年上半年,集團錄得公司權益持有人應占利潤為人民幣180.5百萬元,較2024年同期實現24.1%的反彈。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.